Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT00758433 Completed - Healthy Volunteers Clinical Trials

Civamide Patch Safety, Tolerability and PK Study

Start date: September 2008
Phase: Phase 1
Study type: Interventional

To evaluate the tolerability of two different strengths of a Civamide Patch (0.0075% and 0.0150%) compared to the placebo patch and each other in healthy adult volunteers. To assess the pharmacokinetics of civamide and to determine if there is systemic absorption of the drug from civamide patch in a subset of study subjects.

NCT ID: NCT00757042 Completed - Healthy Volunteers Clinical Trials

Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis

Start date: September 18, 2008
Phase: Phase 1
Study type: Interventional

This study is a single dose escalation study of tezepelumab (AMG 157) in healthy adults (Part A) and adults with moderate to severe atopic dermatitis (Part B). The purpose of the study is to evaluate the safety, tolerability, immunogenicity and pharmacokinetics of tezepelumab.

NCT ID: NCT00756860 Completed - Healthy Volunteers Clinical Trials

A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)

Start date: May 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if subjects on 2g AMG 223 will achieve 60% or greater reduction in urinary phosphorus from baseline compared to subjects on 2g Renagel®. Renagel®, Sevelamer HCl is currently the market leader for the treatment of hyperphosphatemia in patients on dialysis.

NCT ID: NCT00755378 Completed - Healthy Volunteer Clinical Trials

AZD8529 Single Ascending Dose Study

SAD
Start date: September 2008
Phase: Phase 1
Study type: Interventional

This is a study to evaluate safety, tolerability, PK and PD effects of orally administered AZD8529 after single ascending doses

NCT ID: NCT00752141 Completed - Healthy Volunteers Clinical Trials

Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.

NCT ID: NCT00750802 Completed - Healthy Volunteer Clinical Trials

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of the study is to determine the effects of AZD6280 compared to lorazepam on sleepiness, concentration and brain activity.

NCT ID: NCT00749333 Completed - Healthy Volunteer Clinical Trials

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.

Start date: August 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine how well tolerated and safe AZD8566 is at different dose levels. This study will also determine how AZD8566 is distributed around the body and how it leaves the body.

NCT ID: NCT00746837 Completed - Healthy Volunteers Clinical Trials

AZD5672 Absolute Bioavailability Study

Start date: August 2008
Phase: Phase 1
Study type: Interventional

The purpose of the study is to estimate the absolute bioavailability at steady state of 2 doses of AZD5672 (50 mg and 150 mg administered orally once daily)

NCT ID: NCT00746733 Completed - Healthy Volunteers Clinical Trials

Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC

Start date: September 8, 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if taking Vyvanse with Prilosec OTC or Adderall XR with Prilosec OTC changes how quickly the drug is absorbed into the body and/or changes how much of the drug is absorbed into the body.

NCT ID: NCT00742989 Completed - Healthy Volunteers Clinical Trials

Effect of Osteopathic Lymphatic Treatment on Plasma Volume, Protein Concentration and Albumin Concentration.

Start date: May 2005
Phase: N/A
Study type: Interventional

The goal of this project is to see how much an osteopathic lymphatic treatment (OLT) causes an increase in plasma volume, total plasma protein concentration, and albumin concentration. This is an important step in understanding the effects of OLT, specifically its effects on fluid in the body. The primary role of the lymph system is the return of fluid and proteins lost from the blood vessels. Despite this, no research has been done to see what effects an OLT has on fluid and protein levels in the blood.